Author:
Von Holle Ann,O’Brien Katie M.,Sandler Dale P.,Janicek Robert,Karagas Margaret R.,White Alexandra J.,Niehoff Nicole M.,Levine Keith E.,Jackson Brian P.,Weinberg Clarice R.
Abstract
AbstractIron status is often assessed in epidemiologic studies, and toenails offer a convenient alternative to serum because of ease of collection, transport, and storage, and the potential to reflect a longer exposure window. Very few studies have examined the correlation between serum and toenail levels for trace metals. Our aim was to compare iron measures using serum and toenails on both a cross-sectional and longitudinal basis. Using a subset of the US-wide prospective Sister Study cohort, we compared toenail iron measures to serum concentrations for iron, ferritin and percent transferrin saturation. Among 146 women who donated both blood and toenails at baseline, a subsample (59%, n = 86) provided specimens about 8 years later. Cross-sectional analyses included nonparametric Spearman’s rank correlations between toenail and serum biomarker levels. We assessed within-woman maintenance of rank across time for the toenail and serum measures and fit mixed effects models to measure change across time in relation to change in menopause status. Spearman correlations at baseline (follow-up) were 0.08 (0.09) for serum iron, 0.08 (0.07) for transferrin saturation, and − 0.09 (− 0.17) for ferritin. The within-woman Spearman correlation for toenail iron between the two time points was higher (0.47, 95% CI 0.30, 0.64) than for serum iron (0.30, 95% CI 0.09, 0.51) and transferrin saturation (0.34, 95% CI 0.15, 0.54), but lower than that for ferritin (0.58, 95% CI 0.43, 0.73). Serum ferritin increased over time while nail iron decreased over time for women who experienced menopause during the 8-years interval. Based on cross-sectional and repeated assessments, our evidence does not support an association between serum biomarkers and toenail iron levels. Toenail iron concentrations did appear to be moderately stable over time but cannot be taken as a proxy for serum iron biomarkers and they may reflect physiologically distinct fates for iron.
Funder
National Institute of Environmental Health Sciences
Publisher
Springer Science and Business Media LLC
Reference60 articles.
1. Garcia-Casal, M. N., Pasricha, S.-R., Martinez, R. X., Lopez-Perez, L. & Peña-Rosas, J. P. Serum or plasma ferritin concentration as an index of iron deficiency and overload. Cochr. Database Syst. Rev. 5, CD011817 (2021).
2. Brissot, P. Iron overload: Diagnosis, complications, and management. In Nonmalignant Hematology: Expert Clinical Review: Questions and Answers (eds Abutalib, S. A. et al.) 103–112 (Springer, 2016). https://doi.org/10.1007/978-3-319-30352-9_11.
3. Pfeifhofer-Obermair, C., Tymoszuk, P., Petzer, V., Weiss, G. & Nairz, M. Iron in the tumor microenvironment—Connecting the dots. Front. Oncol. 8, 549 (2018).
4. Quintana Pacheco, D. A. et al. Iron status in relation to cancer risk and mortality: Findings from a population-based prospective study. Int. J. Cancer 143, 561–569 (2018).
5. Khan, A., Singh, P. & Srivastava, A. Iron: Key player in cancer and cell cycle?. J. Trace Elem. Med. Biol. 62, 126582 (2020).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Assessment of iron status;Current Opinion in Clinical Nutrition & Metabolic Care;2024-06-07